Latest Nebulizer Stories
MUNICH and MONTEREY, Calif., May 7 /PRNewswire/ -- PARI Pharma GmbH received an Orphan Drug Designation (ODD) by the European Commission based on a positive recommendation by the EMEA for inhaled PARI Tobramycin 100 delivered via a customized Investigational eFlow Nebulizer System.
Presently No Approved Treatments MONMOUTH JUNCTION, N.J., April 21 /PRNewswire/ -- Transave, Inc., today reported completion of patient enrollment in a Phase II study evaluating the safety and efficacy of Arikace(TM) (liposomal amikacin for inhalation) in non-cystic fibrosis (CF) bronchiectasis patients.
MIDLOTHIAN, Va., March 30 /PRNewswire/ -- PARI Respiratory Equipment's LC Sprint reusable nebulizer and TREK S portable compressor were both used in the filming of the final episode of "ER" that will air Thursday at 9pm on NBC.
MIDLOTHIAN, Va., Feb. 10 /PRNewswire/ -- Today, PARI Respiratory Equipment launched two updated continuing education classes, rounding out their free learning program with seven classes for respiratory therapists, nurses, case managers, and pharmacists.
Mexico City-based distributor of Omron products becomes a wholly-owned subsidiary of Omron Healthcare, Inc. BANNOCKBURN, Ill., Feb. 5 /PRNewswire/ -- Omron Healthcare, Inc.
JEFFERSON, N.C., Dec. 15 /PRNewswire/ -- Inhalers used for delivering albuterol, a fast-acting bronchial dilator, currently use propellants such as ozone-depleting CFC's, which are banned by the FDA beginning December 31st, 2009, or replacement HFA's.
BANNOCKBURN, Ill., Dec. 4 /PRNewswire/ -- Omron Healthcare, Inc.
MIDLOTHIAN, Virginia, Nov. 12 /PRNewswire/ -- On Saturday, November 15, PARI Respiratory Equipment will be featured on the ABC Family show Today's Family, as part of their "Breathe Easier" series.
MONTEREY, Calif., Nov.
MIDLOTHIAN, Va., Oct. 28 /PRNewswire/ -- Today, PARI Respiratory Equipment presented a comparative study of three commercially available, breath-enhanced nebulizers and their in-vitro performance and delivery efficiency of budesonide inhalation suspension (Pulmicort Respules, AstraZeneca).
- A political dynamiter.